Side effects are typically only experienced in the first few weeks of treatment, then subside for most patients
Semaglutide represents a significant step forward in the treatment of type 2 diabetes, offering benefits in both blood sugar regulation and weight management
Enteroendocrine L-cells in the lower gut release GLP-1 in response to nutrients and microbial metabolites, influencing satiety, gastric emptying, and glucose-dependent insulin secretion
Effects of exenatide alone and in combination with daclizumab on beta-cell function in long-standing type 1 diabetes
Furthermore, it was found that HL and HG can induce GDM in pregnant rats, leading to the damage of rats placenta (He et al., 2021)
Z-VAD-FMK is due to oxidative stress via the depletion of GSH